Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
Go back to Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma| Cerus Corp (NASDAQ: CERS) | Delayed: 3.16 +0.16 (5.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $7.64 | |||
| Open | $3.04 | 52 Week Low | $4.22 | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.03 | EPS | $-0.59 | |||
| Volume | 3,298,417 | |||||
